What are the recommended medications for treating asthma in adults?

Medication for Asthma in Adults

Inhaled corticosteroids (ICS) are the most effective long-term control medication for persistent asthma in adults and should be the foundation of treatment, with short-acting beta-agonists (SABA) used only for quick relief—never as monotherapy. 1, 2

Long-Term Controller Medications

First-Line: Inhaled Corticosteroids

ICS are the most consistently effective medications at all steps of care for persistent asthma. They reduce airway hyperresponsiveness, inhibit inflammatory cell migration, and improve asthma control more effectively than any other single long-term control medication. 1, 2

Key dosing approach:

• Start with low-to-medium doses for mild-to-moderate persistent asthma
• Can increase up to 2000 µg beclomethasone equivalent daily if needed 3
• Use twice daily dosing; if control inadequate, try four times daily at same total dose before increasing total dose 3
• Require 1-3 months of stability before attempting stepwise reduction (decrease by 25-50% per step) 3

Combination Therapy: ICS + Long-Acting Beta-Agonists (LABA)

For moderate-to-severe persistent asthma, adding a LABA to ICS is the preferred adjunctive therapy over increasing ICS dose alone. 4

This combination provides:

• Superior symptom control compared to ICS monotherapy
• Better outcomes than doubling ICS dose
• Evidence grade A support for efficacy 4

Critical safety warning: LABAs must NEVER be used as monotherapy—only in combination with ICS. 1

Preferred regimen for moderate-severe asthma: ICS-formoterol as both maintenance and reliever therapy (MART approach), where the same combination inhaler is used daily and as-needed for symptoms. 5, 6

Alternative Controller Options

Leukotriene receptor antagonists (LTRAs):

• Alternative (not preferred) for mild persistent asthma (step 2 care)
• Can be added to ICS, but LABA addition is preferred in adults ≥12 years
• Easier to use with high compliance rates 1, 2
• FDA issued Boxed Warning for montelukast in March 2020 5

Other alternatives:

• Cromolyn sodium/nedocromil: Alternative for mild persistent asthma; can prevent exercise-induced symptoms 1
• Theophylline: Mild-to-moderate bronchodilator requiring serum monitoring 1

Severe Asthma Add-On Therapies

Long-acting muscarinic antagonists (LAMAs):

• Recommended when asthma not controlled on ICS-LABA (step 5 care) 6

Biologics for severe persistent asthma:

• Omalizumab (anti-IgE): For patients ≥12 years with allergen sensitivity requiring step 5-6 care 1
• Anti-IL-5 agents (mepolizumab, reslizumab): For severe eosinophilic asthma 7, 8
• Clinicians must be prepared to treat potential anaphylaxis 1

Oral systemic corticosteroids:

• Reserved for severe persistent asthma (step 6 care) requiring long-term control 1

Quick-Relief Medications

Short-acting beta-agonists (albuterol, levalbuterol, pirbuterol):

• Treatment of choice for acute symptom relief
• Prevention of exercise-induced bronchoconstriction
• Warning sign: Using SABA >2 days/week for symptom relief (excluding exercise prevention) indicates inadequate control and need to intensify anti-inflammatory therapy 1, 2
• Regular daily chronic use is NOT recommended 1

Anticholinergics (ipratropium):

• Provides additive benefit to SABA in moderate-severe exacerbations in emergency settings
• Alternative for patients intolerant to SABA 1

Exacerbation Management

For moderate-to-severe exacerbations:

• Oral systemic corticosteroids (prednisolone 30-60 mg) speed recovery and prevent relapse 1, 2
• Short courses (up to 2 weeks) don't require tapering 3
• High-dose inhaled beta-agonists via nebulizer or spacer device 9

Common Pitfalls to Avoid

1. Never prescribe SABA alone for persistent asthma—this increases exacerbation risk and mortality
2. Don't use LABAs as monotherapy—always combine with ICS
3. Don't ignore increasing SABA use—this signals loss of control requiring treatment intensification
4. Don't forget spacer devices—they significantly improve ICS effectiveness 3
5. Verify inhaler technique—poor technique is a major cause of treatment failure 1, 3

Stepwise Treatment Algorithm

Step 1 (Intermittent): As-needed SABA only

Step 2 (Mild persistent): Daily low-dose ICS + as-needed SABA (preferred) OR as-needed ICS-formoterol 5, 6

Step 3 (Moderate persistent): Low-dose ICS-formoterol as maintenance and reliever (preferred) 5, 6

Step 4: Medium-dose ICS-formoterol as maintenance and reliever 5, 6

Step 5: High-dose ICS-LABA + consider adding LAMA 6

Step 6: Add oral systemic corticosteroids and/or biologics 1, 5

Before stepping up therapy, always verify medication adherence, inhaler technique, environmental trigger control, and comorbid conditions (rhinitis, GERD, OSA). 1